PBYI - Puma Biotechnology Non-GAAP EPS of $0.21 beats by $0.20 revenue of $55.4M beats by $8.23M
Puma Biotechnology press release (NASDAQ:PBYI): Q4 Non-GAAP EPS of $0.21 beats by $0.20. Revenue of $55.4M (+5.3% Y/Y) beats by $8.23M. Cash, equivalents, and marketable securities of $82.1 million, compared to cash, cash equivalents, and marketable securities of $93.4 million at December 31, 2020.
For further details see:
Puma Biotechnology Non-GAAP EPS of $0.21 beats by $0.20, revenue of $55.4M beats by $8.23M